Search results for "Digestive System"

showing 10 items of 1747 documents

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association

2009

Hepatocellular carcinoma (HCC) is the most frequent primary neoplasm of the liver, and is the fourth most common malignancy worldwide. It is also the third leading cause of cancer-related deaths. Most cases of HCC develop on a pre-existing chronic liver disease, usually due to hepatitis C virus (HCV), hepatitis B virus (HBV), or alcohol. However, between 15% and 50% of HCC develops in the absence of a known etiology of liver disease, and different lines of evidence identify in non-alcoholic fatty liver disease (NAFLD) a possible relevant risk factor for occurrence of HCC. Insulin resistance (IR), steatosis, oxidative stress and imbalances in adipokine/cytokine interplay, the most important …

Pathologymedicine.medical_specialtyCarcinoma HepatocellularHepatitis C virusmedicine.disease_causeChronic liver diseaseLiver diseaseRisk FactorsDrug DiscoveryDiabetes MellitusmedicineAnimalsHumansObesityLiver Diseases AlcoholicPharmacologyHepatitis B virusSettore MED/12 - Gastroenterologiabusiness.industryLiver NeoplasmsFatty livermedicine.diseasedigestive system diseasesFatty LiverHepatocellular carcinomaCancer researchnafld hepatocellular carcinoma steatosisSteatosisbusinessLiver cancerCurrent Pharmaceutical Design
researchProduct

Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma

2006

Overexpression of T-cadherin (T-cad) transcripts occurs in approximately 50% of human hepatocellular carcinomas (HCCs). To elucidate T-cad functions in HCC, we examined T-cad protein expression in normal and tumoral human livers and hepatoma cell lines and investigated its influence on invasive potential of HCC using RNA interference silencing of T-cad expression in Mahlavu cells. Whereas T-cad expression was restricted to endothelial cells (EC) from large blood vessels in normal livers, it was up-regulated in sinusoidal EC from 8/15 invasive HCCs. Importantly, in three of them (38%) T-cad was detected in tumor cells within regions in which E-cadherin expression was absent. Among six hepato…

Pathologymedicine.medical_specialtyCarcinoma HepatocellularTranscription GeneticLiver cytologyCell Culture TechniquesMotilityBiologyTransfectionBiochemistryRNA interferenceCell MovementCell Line TumorGeneticsmedicineGene silencingAnimalsHumansNeoplasm Invasivenesscardiovascular diseasesRNA Small InterferingMolecular BiologyDNA PrimersWound Healingprimary tumors cadherin switch cell invasion hepatoma cell lines RNA interferenceLiver NeoplasmsEndothelial CellsTransfectionHCCSFibroblastsCadherinsdigestive system diseasesT-cadherinLiverCell cultureCancer researchHepatocytesRabbitsCell DivisionBiotechnology
researchProduct

Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury.

2012

Background Biliary obstruction and cholestasis are serious complications of many liver diseases. Although resident hepatic macrophages (Kupffer cells) are frequently implicated in disease progression, most studies fail to differentiate the contribution of Kupffer cells and inflammatory mononuclear phagocytes (iMNPs) that infiltrate the liver subsequent to obstruction. Aim This study was undertaken to examine the roles and potential interactions of these two disparate mononuclear phagocyte populations in hepatic injury attending cholestasis. Methods Female, C57Bl/6 mice were injected with magnetic beads on day 3 prior to sham operation or bile duct ligation (BDL) to facilitate subsequent Kup…

Pathologymedicine.medical_specialtyChemokineLiver cytologyKupffer Cellsmedicine.medical_treatmentInflammationCholestasis IntrahepaticBiologyReal-Time Polymerase Chain Reactiondigestive systemMiceCholestasismedicineAnimalsMononuclear Phagocyte SystemLiver injuryHepatologyKupffer cellMononuclear phagocyte systemmedicine.diseaseFlow CytometrySpecific Pathogen-Free OrganismsMice Inbred C57BLmedicine.anatomical_structureCytokineImmunologybiology.proteinFemalemedicine.symptomLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Microsatellite Instability in Colorectal Cancer: Time to Stop Hiding!

2011

Colorectal cancer (CRC) is the second cause of cancer-related death worldwide. Surgery constitutes the primary therapy for these tumors, together with chemotherapy that is usually recommended in patients with metastatic primary CRC. Although molecularly distinct entities arising from different physiopathogenic mechanisms - microsatellite (MSI) and chromosomal instability (also called microsatellite stable, MSS) - have been characterized in CRC, there is still no specific therapeutic approach that takes into account disease’s molecular heterogeneity [1]. MSI is observed in 1015% of sporadic CRCs. MSI CRCs displayed particular morphologic features, with greater predilection for the right colo…

Pathologymedicine.medical_specialtyChemotherapyColorectal cancermedicine.medical_treatmentMicrosatellite instabilityDiseaseBiologymedicine.diseasedigestive system diseasesTherapeutic approachOncologyChromosome instabilityCancer researchmedicineMicrosatelliteAnimalsHumansIn patientMicrosatellite InstabilityHSP110 Heat-Shock ProteinsColorectal NeoplasmsneoplasmsEditorial CommentsOncotarget
researchProduct

Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease.

2021

Hepatocellular carcinoma (HCC) is the most common liver malignancy associated with chronic liver disease. Nonhepatocellular malignancies may also arise in the setting of chronic liver disease. The imaging diagnosis of non-HCC malignancies may be challenging. Non-HCC malignancies in patients with chronic liver disease most commonly include intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma, and less commonly hepatic lymphomas and metastases. On MR imaging, non-HCC malignancies often demonstrate a targetoid appearance, manifesting as rim arterial phase hyperenhancement, peripheral washout, central delayed enhancement, and peripheral restricted diffusion. When apply…

Pathologymedicine.medical_specialtyCirrhosisCarcinoma HepatocellularHepatocellular carcinomaLiver imaging reporting and data systemContrast MediaMalignancyChronic liver diseaseMetastasisMetastasismedicineHumansRadiology Nuclear Medicine and imagingneoplasmsIntrahepatic CholangiocarcinomaIntrahepatic cholangiocarcinomaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsMagnetic resonance imagingCombined hepatocellular-cholangiocarcinomamedicine.diseaseMagnetic Resonance Imagingdigestive system diseasesBile Ducts IntrahepaticBile Duct NeoplasmsHepatocellular carcinomabusinessArterial phaseMagnetic resonance imaging clinics of North America
researchProduct

Animal models of non-alcoholic steatohepatitis: of mice and man.

2010

The epidemic occurrence of obesity has led to a rapid increase in the incidence of non-alcoholic fatty liver disease (NAFLD) in industrial countries. The disease spectrum includes hepatic steatosis, lobular inflammation with steatohepatitis (NASH) and varying degrees of liver fibrosis, which can progress to cirrhosis. Hepatocellular carcinoma can develop in patients with NASH, even in the absence of cirrhosis. The majority of patients with primary NASH exhibit risk factors that define the metabolic syndrome including insulin resistance and visceral obesity. However, only a minority of patients with NAFLD progress to end-stage liver disease and, so far, predictors to identify these patients …

Pathologymedicine.medical_specialtyCirrhosisDiseaseBioinformaticsLiver diseaseMiceMethionineGenetic predispositionMedicineAnimalsHumansbusiness.industryFatty liverGastroenterologyGeneral Medicinemedicine.diseaseDietary Fatsdigestive system diseasesCholine DeficiencyFatty LiverDisease Models AnimalLiverSteatosisMetabolic syndromeSteatohepatitisbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.

1993

The expression of intercellular adhesion molecule-1 (ICAM-1, CD54) was examined in 16 surgically removed colonic tumours and two colonic carcinoma cell lines. Immunohistochemistry showed a varying percentage of ICAM-1 positive colonic carcinoma cells in 9/16 tissue specimens, while normal colonic tissue (apart from a slight reactivity of endothelial cells) was not stained. The presence of the ICAM-1 molecule on the cell surface and the expression of ICAM-1 mRNA were investigated for two colonic carcinoma cell lines. It was possible to enhance the expression of ICAM-1 considerably by incubating the cells in the presence of inflammatory cytokines in HT-29 and CaCo-2 cells. The responsiveness …

Pathologymedicine.medical_specialtyColonMolecular Sequence DataCellIntercellular Adhesion Molecule-1Alpha interferonBiologyInflammatory bowel diseaseEpitheliumProinflammatory cytokineTumor Cells CulturedmedicineHumansIntestinal MucosaBase SequenceGastroenterologyBlotting NorthernInflammatory Bowel DiseasesIntercellular Adhesion Molecule-1medicine.diseaseMolecular biologydigestive system diseasesEpitheliumNeoplasm Proteinsmedicine.anatomical_structureCell cultureColonic NeoplasmsImmunohistochemistryCell Adhesion MoleculesResearch ArticleGut
researchProduct

Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case.

2011

Colon carcinoma rarely metastasizes to the breast and it is usually associated with a poor prognosis. Even rarer is metastatic seeding of colon cancer cells in an intramammary location after surgery. Including a primary breast malignancy in the differential diagnosis of such cases is mandatory. We report a rare case of double seeding implantation of colon adenocarcinoma inside the breast parenchyma and intercostal muscles 6 years after resection of a pulmonary metastasis from colon adenocarcinoma. The metastasis was revealed by the presence of bone metaplasia in the intercostal muscles. We discuss how negative immunostaining for estrogen receptors, progesterone receptors, and HER-2, along w…

Pathologymedicine.medical_specialtyColorectal cancerReceptor ErbB-2Estrogen receptorNeoplasm SeedingBreast NeoplasmsIntercostal MusclesSettore MED/08 - Anatomia PatologicaAdenocarcinomaBone and BonesMetastasisCytokeratinNeoplasm SeedingMetaplasiamedicineCarcinomaHumansAgedMetaplasiabusiness.industryGeneral MedicineThoracic Neoplasmsmedicine.diseasedigestive system diseasesSettore MED/18 - Chirurgia GeneraleMetastatic seeding colon adenocarcinoma breast cdx2ck20 ck7Receptors EstrogenColonic NeoplasmsSurgeryFemaleDifferential diagnosismedicine.symptombusinessReceptors ProgesteroneSurgery today
researchProduct

ADVANCED ENDOSCOPIC IMAGING FOR SURVEILLANCE FOR DYSPLASIA AND COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE: COULD THE PATHOLOGIST BE FURTHER HELP…

2014

Patients with inflammatory bowel disease (IBD) have an increased risk of developing intestinal cancer. The magnitude of that increased risk as well as how best to mitigate it remain a topic of ongoing investigation in the field. It is important to quantify the risk of colorectal cancer in association with IBD. The reported risk varies widely between studies. This is partly due to the different methodologies used in the studies. Because of the limitations of surveillance strategies based on the detection of dysplasia, advanced endoscopic imaging and techniques involving the detection of alterations in mucosal antigens and genetic abnormalities are being investigated. Development of new bioma…

Pathologymedicine.medical_specialtyColorectal cancerReview ArticleComorbidityInflammatory bowel diseaseEndoscopy GastrointestinalADVANCED ENDOSCOPIC IMAGING DYSPLASSIA COLON CANCER IBDEndoscopic imagingRisk Factorsinflammatory bowel diseasemedicineHumanslcsh:RC799-869Intestinal Cancerulcerative colitisPatient Care TeamCrohn's diseaseSettore MED/12 - GastroenterologiaMicroscopy Confocalbusiness.industryCrohn′s diseaseGastroenterologyInflammatory Bowel Diseasesmedicine.diseaseUlcerative colitisColorectal cancerdigestive system diseasesCrohn's diseaseSettore MED/18 - Chirurgia GeneraleDysplasiaPopulation SurveillancesurveillanceBiomarker (medicine)lcsh:Diseases of the digestive system. GastroenterologyColorectal Neoplasmsbusiness
researchProduct

Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas.

1987

We studied the expression of villin, a microfilament-associated, actin-binding protein typical of brush-border microvilli, in a variety of human carcinomas by applying immunofluorescence microscopy to frozen sections and immunoblotting methods to tissue extracts using a rabbit antiserum and a monoclonal antibody specific for villin. All of the 24 primary and metastatic colorectal adenocarcinomas tested were uniformly and strongly positive for villin, with the immunocytochemical labeling concentrated at the luminal cell margin. In poorly differentiated tumor areas, rudimentary tubules were stained. All of the six tubular adenocarcinomas of the stomach studied as well as two adenocarcinomas o…

Pathologymedicine.medical_specialtyFluorescent Antibody Techniquemacromolecular substancesChromophobe cellAdenocarcinomadigestive systemMetastasisImmunoenzyme TechniquesmedicineBiomarkers TumorHumansbiologyMicrofilament ProteinsAntibodies Monoclonalmedicine.diseasePrimary tumorMicroscopy FluorescenceDysplasiabiology.proteinImmunologic TechniquesAdenocarcinomaImmunohistochemistryVillinCarrier ProteinsClear cellVirchows Archiv. B, Cell pathology including molecular pathology
researchProduct